Sponsor pipeline

Anthos Therapeutics, Inc. clinical trial pipeline

Get alerts when Anthos Therapeutics, Inc.'s trials change

2 active trials 1 recruiting 1 Phase 3 2 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

Active trials by phase

Phase 2
1
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05712200 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial… Atrial Fibrillation (AF) Recruiting 2026-07-13
Phase 2
NCT04755283 Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial… Atrial Fibrillation (AF) Active, Not Recruiting 2025-11-06

Disease areas by active trials

Atrial Fibrillation (2) · Stroke (1)

Get alerts when Anthos Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free